Rapid Micro Biosystems (RPID) Cash from Financing Activities (2020 - 2026)

Rapid Micro Biosystems has disclosed Cash from Financing Activities across 7 years of filings, most recently posting $247000.0 for Q1 2026.

• Cash from Financing Activities for Q1 2026 came in at $247000.0, down 34.83% year-over-year; the trailing twelve-month figure through Mar 2026 was $19.6 million (up 4531.84% YoY), and the FY2025 annual result was $19.8 million, up 9639.41% from the prior year.
• Cash from Financing Activities came in at $247000.0 for Q1 2026 at Rapid Micro Biosystems, down from $443000.0 in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $19.2 million in Q3 2025 to a low of -$298000.0 in Q2 2025.
• The 5-year median for Cash from Financing Activities is $87000.0 (2022), against an average of $1.2 million.
• Peak annual rise in Cash from Financing Activities reached 31452.46% in 2025, while the deepest fall reached 2880.0% in 2025.
• Rapid Micro Biosystems' Cash from Financing Activities stood at $87000.0 in 2022, then slumped by 113.79% to -$12000.0 in 2023, then surged by 50.0% to -$6000.0 in 2024, then soared by 7483.33% to $443000.0 in 2025, then slumped by 44.24% to $247000.0 in 2026.
• The last three Cash from Financing Activities figures came in at $247000.0 (Q1 2026), $443000.0 (Q4 2025), and $19.2 million (Q3 2025), per Business Quant data.